These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8698)

  • 21. Beta1- and beta2-adrenergic receptors responsible for cyclic AMP accumulation in isolated heart and lung cells.
    Hazeki O; Ui M
    Mol Pharmacol; 1980 Jan; 17(1):8-13. PubMed ID: 6104287
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    Mol Pharmacol; 1983 Jan; 23(1):228-34. PubMed ID: 6135143
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adrenergic blockade on gastric secretion altered by catecholamines in rats.
    Hano J; Bugajski J; Danek L
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):507-24. PubMed ID: 11761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine regulation of cyclic 3',5'-adenosine monophosphate formation in rat spinal cord.
    Jones DJ
    J Pharmacol Exp Ther; 1981 Nov; 219(2):370-6. PubMed ID: 6270305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Catecholamines].
    Yamada R
    Horumon To Rinsho; 1971 Oct; 19(10):838-41. PubMed ID: 4401929
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Increase in the cyclic AMP content of rat striatum produced by a cyclic analogue of dopamine.
    Munday KA; Poat JA; Woodruff GN
    J Physiol; 1974 Sep; 241(2):119P-120P. PubMed ID: 4374521
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of striatal cyclic-3',5'-adenosine monophosphate accumulation and GABA release by glutamate metabotropic and dopamine D1 receptors.
    Wang J; Johnson KM
    J Pharmacol Exp Ther; 1995 Nov; 275(2):877-84. PubMed ID: 7473179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neurohumoral and adrenergic agents on cyclic AMP levels in various areas of the rat brain in vitro.
    Palmer GC; Sulser F; Robison GA
    Neuropharmacology; 1973 Apr; 12(4):327-37. PubMed ID: 4145053
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenergic receptors for metabolic responses in adipose tissue.
    Himms-Hagen J
    Fed Proc; 1970; 29(4):1388-401. PubMed ID: 4394105
    [No Abstract]   [Full Text] [Related]  

  • 34. Antagonism of alpha- and beta-adrenergic-mediated accumulations of cyclic AMP in rat cerebral cortical slices by the beta-antagonist (-)alprenolol.
    Skolnick P; Daly JW
    Life Sci; 1976 Aug; 19(4):497-503. PubMed ID: 8683
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of catecholamines on the smooth muscle of the female reproductive tract.
    Marshall JM
    Annu Rev Pharmacol; 1973; 13():19-32. PubMed ID: 4145966
    [No Abstract]   [Full Text] [Related]  

  • 36. Negative chronotropic effect of catecholamines on adrenergic receptors in cardiac ganglia in the spinal dog.
    Kushiku K; Furukawa T; Ichimasa S; Kamiya H
    J Cardiovasc Pharmacol; 1980; 2(6):857-66. PubMed ID: 6160334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic control of glucose output and adenosine 3':5'-monophosphate levels in hepatocytes from juvenile and adult rats.
    Blair JB; James ME; Foster JL
    J Biol Chem; 1979 Aug; 254(16):7579-84. PubMed ID: 38243
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines.
    Schwartz JC; Costentin J; Martres MP; Protais P; Baudry M
    Neuropharmacology; 1978 Sep; 17(9):665-85. PubMed ID: 211458
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of acrylamide treatment upon the dopamine receptor.
    Agrawal AK; Squibb RE; Bondy SC
    Toxicol Appl Pharmacol; 1981 Mar; 58(1):89-99. PubMed ID: 6112805
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of apomorphine on dopamine turnover and adenosine 3',5'-monophosphate content in striatum of morphine-dependent rats.
    Puri SK; Volicer L; Lal H
    Neuropharmacology; 1977 Mar; 16(3):205-9. PubMed ID: 190557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.